These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 26824324

  • 1. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
    Liu Z, Qi S, Zhao X, Li M, Ding S, Lu J, Zhang H.
    Oncotarget; 2016 Apr 19; 7(16):21315-31. PubMed ID: 26824324
    [Abstract] [Full Text] [Related]

  • 2. Dual-specificity phosphatase 6 (Dusp6), a negative regulator of FGF2/ERK1/2 signaling, enhances 17β-estradiol-induced cell growth in endometrial adenocarcinoma cell.
    Zhang H, Guo Q, Wang C, Yan L, Fu Y, Fan M, Zhao X, Li M.
    Mol Cell Endocrinol; 2013 Aug 25; 376(1-2):60-9. PubMed ID: 23419500
    [Abstract] [Full Text] [Related]

  • 3. Normal endometrial stromal cells regulate 17β-estradiol-induced epithelial-mesenchymal transition via slug and E-cadherin in endometrial adenocarcinoma cells in vitro.
    Zhang H, Li H, Qi S, Liu Z, Fu Y, Li M, Zhao X.
    Gynecol Endocrinol; 2017 Jan 25; 33(1):82-86. PubMed ID: 27449470
    [Abstract] [Full Text] [Related]

  • 4. The effect of estrogen on the proliferation of endometrial cancer cells is mediated by ERRγ through AKT and ERK1/2.
    Sun Y, Wang C, Yang H, Ma X.
    Eur J Cancer Prev; 2014 Sep 25; 23(5):418-24. PubMed ID: 25068805
    [Abstract] [Full Text] [Related]

  • 5. Crosstalk between estrogen receptor and mitogen-activated protein kinase signaling in the development and progression of endometrial cancer.
    Zhou L, Cai B, Bao W, He YY, Chen XY, Yang YX, Liu XL, Wan XP.
    Int J Gynecol Cancer; 2011 Nov 25; 21(8):1357-65. PubMed ID: 21720253
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effects of metformin on the estrogen-induced proliferation and the expression of ER in human endometrial cancer cells].
    Zhang J, Zhang B, Yin Z, Chen F, Liu T, Xu H, Liu Y, Zhou X.
    Zhonghua Fu Chan Ke Za Zhi; 2014 Dec 25; 49(12):932-7. PubMed ID: 25608995
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Melatonin Inhibits 17β-Estradiol-Induced Epithelial-Mesenchymal Transition in Endometrial Adenocarcinoma Cells via Upregulating Numb Expression.
    Zhang H, Qi S, Liu Z, Li C, Li M, Zhao X.
    Gynecol Obstet Invest; 2022 Dec 25; 87(2):89-99. PubMed ID: 35130539
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
    Bhat KP, Pezzuto JM.
    Cancer Res; 2001 Aug 15; 61(16):6137-44. PubMed ID: 11507064
    [Abstract] [Full Text] [Related]

  • 14. Kallikrein 4 overexpression in endometrial carcinoma and upregulation by estrogen via mitogen-activated protein kinase signal pathway.
    Zhang SQ, Cai B, Liu L, He YY, Yang YX, Wan XP.
    Int J Gynecol Cancer; 2009 Nov 15; 19(8):1377-83. PubMed ID: 20009893
    [Abstract] [Full Text] [Related]

  • 15. ATX‑LPA axis facilitates estrogen‑induced endometrial cancer cell proliferation via MAPK/ERK signaling pathway.
    Zhang G, Cheng Y, Zhang Q, Li X, Zhou J, Wang J, Wei L.
    Mol Med Rep; 2018 Mar 15; 17(3):4245-4252. PubMed ID: 29328374
    [Abstract] [Full Text] [Related]

  • 16. Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosis.
    Xue J, Zhang H, Liu W, Liu M, Shi M, Wen Z, Li C.
    Reproduction; 2013 Oct 15; 146(4):397-406. PubMed ID: 23904524
    [Abstract] [Full Text] [Related]

  • 17. Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines.
    Laskov I, Abou-Nader P, Amin O, Philip CA, Beauchamp MC, Yasmeen A, Gotlieb WH.
    Int J Gynecol Cancer; 2016 Sep 15; 26(7):1213-21. PubMed ID: 27643646
    [Abstract] [Full Text] [Related]

  • 18. Brain-Derived Neurotrophic Factor Regulates Ishikawa Cell Proliferation through the TrkB-ERK1/2 Signaling Pathway.
    Cao M, Niu Q, Xiang X, Yuan C, Iqbal T, Huang Y, Tian M, Zhao Z, Li C, Zhou X.
    Biomolecules; 2020 Dec 08; 10(12):. PubMed ID: 33302387
    [Abstract] [Full Text] [Related]

  • 19. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation.
    Wei Y, Zhang Z, Liao H, Wu L, Wu X, Zhou D, Xi X, Zhu Y, Feng Y.
    Oncol Rep; 2012 Feb 08; 27(2):504-10. PubMed ID: 22075757
    [Abstract] [Full Text] [Related]

  • 20. High Glucose Promotes Epithelial-Mesenchymal Transition of Uterus Endometrial Cancer Cells by Increasing ER/GLUT4-Mediated VEGF Secretion.
    Gu CJ, Xie F, Zhang B, Yang HL, Cheng J, He YY, Zhu XY, Li DJ, Li MQ.
    Cell Physiol Biochem; 2018 Feb 08; 50(2):706-720. PubMed ID: 30308493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.